276 related articles for article (PubMed ID: 7909227)
1. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD
AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227
[TBL] [Abstract][Full Text] [Related]
2. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Kappes JC; Saag MS; Shaw GM; Hahn BH; Chopra P; Chen S; Emini EA; McFarland R; Yang LC; Piatak M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):139-49. PubMed ID: 7552477
[TBL] [Abstract][Full Text] [Related]
3. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
[TBL] [Abstract][Full Text] [Related]
4. Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
Tamalet C; Masquelier B; Ferchal F; Agut H; Puel J; Brun-Vézinet F; Fleury H; Rouzioux C
AIDS; 1992 Nov; 6(11):1403-4. PubMed ID: 1361750
[No Abstract] [Full Text] [Related]
5. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription.
Kojima E; Shirasaka T; Anderson B; Chokekijchai S; Sei S; Yarchoan R; Mitsuya H
AIDS; 1993 Nov; 7 Suppl 2():S101-5. PubMed ID: 8161438
[TBL] [Abstract][Full Text] [Related]
7. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
Aoki-Sei S; Yarchoan R; Kageyama S; Hoekzema DT; Pluda JM; Wyvill KM; Broder S; Mitsuya H
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1263-70. PubMed ID: 1520538
[TBL] [Abstract][Full Text] [Related]
8. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes.
Mole L; Margolis D; Carroll R; Todd J; Holodniy M
J Clin Microbiol; 1994 Sep; 32(9):2212-5. PubMed ID: 7814549
[TBL] [Abstract][Full Text] [Related]
9. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients.
Bush CE; Donovan RM; Manzor O; Baxa D; Moore E; Cohen F; Saravolatz LD
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):11-5. PubMed ID: 8825613
[TBL] [Abstract][Full Text] [Related]
11. High levels of circulating RNA in patients with symptomatic HIV-1 infection.
Baumberger C; Kinloch-de-Loës S; Yerly S; Hirschel B; Perrin L
AIDS; 1993 Nov; 7 Suppl 2():S59-64. PubMed ID: 7909226
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
13. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay.
Urdea MS; Wilber JC; Yeghiazarian T; Todd JA; Kern DG; Fong SJ; Besemer D; Hoo B; Sheridan PJ; Kokka R
AIDS; 1993 Nov; 7 Suppl 2():S11-4. PubMed ID: 8161440
[TBL] [Abstract][Full Text] [Related]
14. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
[TBL] [Abstract][Full Text] [Related]
16. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals.
Ribas SG; Ondoa P; Schüpbach J; van der Groen G; Fransen K
J Virol Methods; 2003 Oct; 113(1):29-34. PubMed ID: 14500124
[TBL] [Abstract][Full Text] [Related]
17. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
[TBL] [Abstract][Full Text] [Related]
18. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.
Böni J; Opravil M; Tomasik Z; Rothen M; Bisset L; Grob PJ; Lüthy R; Schüpbach J
AIDS; 1997 May; 11(6):F47-52. PubMed ID: 9143600
[TBL] [Abstract][Full Text] [Related]
19. Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
Muñoz-Fernández MA; Navarro J; Montes MG; Cosín J; Zabay JM; Fernández-Cruz E
J Clin Microbiol; 1996 Feb; 34(2):404-8. PubMed ID: 8789024
[TBL] [Abstract][Full Text] [Related]
20. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
Semple M; Loveday C; Weller I; Tedder R
J Med Virol; 1991 Sep; 35(1):38-45. PubMed ID: 1940882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
